title: COX-2 inhibitors and the thrombotic risk.
authors.forename: Karsten
authors.initials: K
authors.lastname: Schrör
authors.forename: Artur-Aron
authors.initials: AA
authors.lastname: Weber
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D015232:Dinoprostone / Q000378:metabolism; D011464:Epoprostenol / Q000378:metabolism; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000378:metabolism; D018570:Risk Assessment; D013927:Thrombosis / Q000139:chemically induced* / Q000378:metabolism; D013928:Thromboxane A2 / Q000378:metabolism
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D013928:Thromboxane A2; D011464:Epoprostenol; D015232:Dinoprostone